November 16, 2021
Nine academics from the UNC Gillings School of Global Public Health were recently named to the 2021 Highly Cited Researchers list from Clarivate.
The highly anticipated annual list identifies researchers who demonstrated significant influence in their chosen field or fields through the publication of multiple highly cited papers during the last decade. Their names are drawn from the publications that rank in the top one percent by citations for field and publication year in the Web of Science™ citation index.
From the Gillings School, those faculty include:
Ralph S. Baric, PhD, William R. Kenan, Jr. Distinguished Professor of epidemiology. Baric has spent the past three decades as a world leader in the study of coronaviruses and is responsible for UNC-Chapel Hill’s world leadership in coronavirus research.
Noel T. Brewer, PhD, Gillings Distinguished Professor in Public Health and professor of health behavior. Brewer’s research explores why people engage in vaccination, vaping and other health behaviors that prevent cancer.
Stephen R. Cole, PhD, professor of epidemiology. Cole studies causal inference and the methods of epidemiology, including the design and analysis of randomized experiments and observational studies.
Kelly R. Evenson, PhD, professor of epidemiology. Evenson’s research focuses on physical activity and sedentary behavior, with specific interests in measurement, surveillance, intervention and associations with outcomes.
Hans W. Paerl, PhD, professor of marine and environmental sciences and engineering and William R. Kenan, Jr. Distinguished Professor at UNC’s Institute of Marine Sciences. Paerl’s research specializes in water quality, eutrophication, harmful algal bloom and food web dynamics of freshwater and marine ecosystems — locally, nationally and internationally.
Barry M. Popkin, PhD, William R. Kenan, Jr. Distinguished Professor of nutrition. Popkin’s research focuses globally on understanding the stages of nutrition transition, which is the study of the dynamic shifts in dietary intake and physical activity patterns and trends around obesity and other nutrition-related noncommunicable diseases.
Bryce Reeve, PhD, professor of population health sciences and Pediatrics within the Duke University School of Medicine, where he directs the Center for Health Measurement. He is also an adjunct professor of health policy and management at the Gillings School. Reeve’s areas of expertise are in developing patient-reported questionnaires using qualitative and quantitative methodologies and the integration of patient-reported data in research and healthcare delivery to inform decision-making.
Timothy Sheahan, PhD, assistant professor of epidemiology. Sheahan is a virologist whose research focuses on understanding emerging viral diseases and developing new means to stop them.
David J. Weber, MD, professor of medicine, pediatrics and epidemiology, associate chief medical officer of UNC Health Care, and director of regulatory services for the North Carolina Translational and Clinical Sciences Institute (NC TraCS). Weber’s research career has focused on healthcare-associated infections, antibiotic stewardship, new and emerging diseases, and vaccine implementation.
The methodology that determines the “who’s who” of influential researchers draws on the data and analysis performed by bibliometric experts and data scientists at the Institute for Scientific Information™ at Clarivate. It also uses the tallies to identify the countries and research institutions where these citation elite are based.
See the full 2021 Highly Cited Researchers list and executive summary and learn more about the methodology.
Contact the UNC Gillings School of Global Public Health communications team at firstname.lastname@example.org.
December 4, 2023 The grant will fund research designed to facilitate more widespread cancer screening and early detection, culminating in reduced cancer mortality. Specifically, the researchers will use data from CIPHR to create new tools based on insurance claims that more efficiently measure and compare cancer screening use across small geographic areas and groups of people.